Exagen Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Exagen Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6411
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole blood and methotrexate polyglutamates, risk assessment testing, anti-TNF monitoring to individualize therapy and optimize dosing, and others. Exagen offers avise ctd, avise sle prognostic, avise infliximab and avise adalimumab, avise hcq, and avise mtx. The company serves physicians and patients. It operates in Vista and Albuquerque, the US. Exagen is headquartered in Vista, California, the US.

Exagen Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exagen Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exagen Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Exagen Diagnostics Raises USD23 Million in Series F Financing 10
Exagen Diagnostics Raises USD3.8 Million in Venture Financing 11
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 12
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in Venture Financing 17
Exagen Diagnostics Raises USD1 Million in Venture Financing 18
Exagen Diagnostics Raises USD1 Million in venture financing 19
Exagen Diagnostics Raises USD2 Million in Venture Financing 20
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 21
Exagen Diagnostics Raises USD3 Million in Venture Financing 22
Exagen Diagnostics Raises USD2 Million in Venture Financing 23
Exagen Diagnostics Raises USD4 Million in Venture Financing 24
Exagen Diagnostics Raises US$5 Million In Venture Financing 25
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 26
Exagen Raises US$5.3 Million In Venture Financing 27
Exagen Diagnostics Inc – Key Competitors 28
Exagen Diagnostics Inc – Key Employees 29
Exagen Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Product News 31
Oct 31, 2017: Exagen Diagnostics Featured in Five Scientific Posters at 2017 ACR/ARHP Annual Meeting in San Diego 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Exagen Diagnostics Inc, Medical Equipment, Key Facts 2
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exagen Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exagen Diagnostics Raises USD23 Million in Series F Financing 10
Exagen Diagnostics Raises USD3.8 Million in Venture Financing 11
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 12
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in Venture Financing 17
Exagen Diagnostics Raises USD1 Million in Venture Financing 18
Exagen Diagnostics Raises USD1 Million in venture financing 19
Exagen Diagnostics Raises USD2 Million in Venture Financing 20
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 21
Exagen Diagnostics Raises USD3 Million in Venture Financing 22
Exagen Diagnostics Raises USD2 Million in Venture Financing 23
Exagen Diagnostics Raises USD4 Million in Venture Financing 24
Exagen Diagnostics Raises US$5 Million In Venture Financing 25
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 26
Exagen Raises US$5.3 Million In Venture Financing 27
Exagen Diagnostics Inc, Key Competitors 28
Exagen Diagnostics Inc, Key Employees 29
Exagen Diagnostics Inc, Other Locations 30

List of Figures
Exagen Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exagen Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exagen Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Exagen Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Slater and Gordon Limited:企業の戦略・SWOT・財務情報
    Slater and Gordon Limited - Strategy, SWOT and Corporate Finance Report Summary Slater and Gordon Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • AVJennings Limited:企業の戦略・SWOT・財務情報
    AVJennings Limited - Strategy, SWOT and Corporate Finance Report Summary AVJennings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • TechnoPhage SA-製薬・医療分野:企業M&A・提携分析
    Summary TechnoPhage SA (TechnoPhage) is a biotechnology company that concentrates on research and development of new molecules. The company conducts research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development services for …
  • Logitech International S.A.:企業の戦略・SWOT・財務分析
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Medica Corp:医療機器:M&Aディール及び事業提携情報
    Summary Medica Corp (Medica) is a medical device company that manufactures and markets in-vitro diagnostic blood testing analyzers. The company’s products comprise clinical chemistry analyzers, electrolyte analyzers, blood gas analyzers, and hematology analyzers, and OEM ISE modules. Medica’s produc …
  • Student Transportation Inc.:企業の戦略・SWOT・財務分析
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Genzyme Corp-製薬・医療分野:企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …
  • HoMedics USA LLC:企業の戦略的SWOT分析
    HoMedics USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Denver Water:企業の戦略的SWOT分析
    Denver Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kotak Wealth Management:企業の戦略・SWOT・財務情報
    Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JSC Inter RAO:企業のM&A・事業提携・投資動向
    JSC Inter RAO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSC Inter RAO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • American Shared Hospital Services (AMS)-医療機器分野:企業M&A・提携分析
    Summary American Shared Hospital Services (ASHS) is a healthcare company that offers medical equipment to hospitals and medical centers. The company offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning an …
  • Humana Inc (HUM)-製薬・医療分野:企業M&A・提携分析
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Marathon Oil Corporation:企業の戦略・SWOT・財務分析
    Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Maerki Baumann & Co. AG:企業の戦略・SWOT・財務情報
    Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Jumboking Foods Pvt. Ltd.
    Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析
    Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • NeoPharm Co Ltd:企業の戦略・SWOT・財務分析
    NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rockland Immunochemicals Inc (Rockland) is a biotechnology company that manufactures research tools for basic, applied and clinical research in functional genomics, drug discovery, gene therapy markets. The company’s products include collagen products, primary and secondary antibodies, Epi-P …
  • Cognoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cognoptix Inc (Cognoptix), formerly Neuroptix Corp is a privately held medical technology company that develops and offers eye-scanning test for the early detection and diagnosis of Alzheimer’s disease. The company develops technology, which is used to detect the presence of Alzheimer’s rela …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆